Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3432380 | American Journal of Obstetrics and Gynecology | 2016 | 11 Pages |
Abstract
Using data from the Get With the Guidelines-Stroke Registry to assemble the largest cohort of pregnant or postpartum ischemic stroke patients who had been treated with reperfusion therapy, we observed that pregnant or postpartum women had similarly favorable short-term outcomes and equal rates of total reperfusion therapy to nonpregnant women, despite lower rates of intravenous tissue plasminogen activator use. Future studies should identify the characteristics of pregnant and postpartum ischemic stroke patients who are most likely to safely benefit from reperfusion therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Lisa R. MD, Caitlin R. BA, Brian T. MD, MSc, Margueritte MS, MGIST, Phillip J. PhD, Eric E. MD, MPH, Gregg C. MD, Elena V. MD, PhD, Mary G. MD, MSPH, Lee H. MD,